In vitro activity of voriconazole against Candida species

被引:31
作者
Kauffman, CA
Zarins, LT
机构
[1] Vet Affairs Med Ctr, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48105 USA
[2] Univ Michigan, Sch Med, Ann Arbor, MI USA
关键词
D O I
10.1016/S0732-8893(98)00005-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The in vitro activity of voriconazole was compared with that of itraconazole and fluconazole against 181 isolates of Candida albicans, 124 isolates of Candida glabrata, and 20 isolates of Candida krusei obtained from the early 1980s through the mid-1990s. Voriconazole had greater intrinsic activity than fluconazole or intraconazole against all three Candida species: For C. glabrata, C. krusei, and C. albicans, the MIC50 values for voriconazole were 1 mu g/mL, 0.5 mu g/mL, and 0.01 mu g/Int, respectively, compared with fluconazole MIC50 values of 8 mu g/mL, 64 mu g/mL, and 0.25 mu g/mL, respectively. If isolates from AIDS patients were excluded, MIC values for isolates from the 1990s were no higher than those noted for isolates from the 1980s. Voriconazole, a new triazole antifungal agent, appears to have enhanced activity against these three species of Candida; the clinical relevance of these findings should be studied in treatment trials. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:297 / 300
页数:4
相关论文
共 17 条
[11]   FLUCONAZOLE SUSCEPTIBILITIES OF CANDIDA SPECIES AND DISTRIBUTION OF SPECIES RECOVERED FROM BLOOD CULTURES OVER A 5-YEAR PERIOD [J].
PRICE, MF ;
LAROCCO, MT ;
GENTRY, LO .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) :1422-1424
[12]   In vitro studies of activity of voriconazole (WK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens [J].
Radford, SA ;
Johnson, EM ;
Warnock, DW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (04) :841-843
[13]   In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection [J].
Ruhnke, M ;
SchmidtWesthausen, A ;
Trautmann, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :575-577
[14]   A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei [J].
Sanati, H ;
Belanger, P ;
Fratti, R ;
Ghannoum, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2492-2496
[15]   EPIDEMIOLOGY OF ORAL CANDIDIASIS IN HIV-INFECTED PATIENTS - COLONIZATION, INFECTION, TREATMENT, AND EMERGENCE OF FLUCONAZOLE RESISTANCE [J].
SANGEORZAN, JA ;
BRADLEY, SF ;
HE, XG ;
ZARINS, LT ;
RIDENOUR, GL ;
TIBALLI, RN ;
KAUFFMAN, CA .
AMERICAN JOURNAL OF MEDICINE, 1994, 97 (04) :339-346
[16]   TORULOPSIS-GLABRATA - AZOLE SUSCEPTIBILITIES BY MICRODILUTION COLORIMETRIC AND MACRODILUTION BROTH ASSAYS [J].
TIBALLI, RN ;
ZARINS, LT ;
HE, XG ;
KAUFFMAN, CA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (10) :2612-2615
[17]  
TROKE PF, 1995, 35 INT C ANT AG CHEM, P125